FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37421211000001102: Reltebon 40mg modified-release tablets (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
319821000001113 Reltebon 40mg modified-release tablets (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
319841000001115 Reltebon 40mg modified-release tablets (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Is a Oxycodone 40mg modified-release tablets true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Is a Reltebon true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Reltebon 40mg modified-release tablets (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Reltebon 40mg modified-release tablets (CST Pharma Ltd) 56 tablet Has AMP True Reltebon 40mg modified-release tablets (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start